Related Experiment Videos
Embryopathic effect of ophthalmic EDTA.
Investigative Ophthalmology & Visual Science
|July 1, 1977
Summary
Topical EDTA (0.1% and 3%) was studied for teratogenic effects. While low-dose EDTA showed no harm, high-dose 3% EDTA applied frequently to the eye caused significant embryopathic effects in progeny.
Area of Science:
- Ophthalmology
- Toxicology
- Developmental Biology
Background:
- Ethylenediaminetetraacetic acid (EDTA) has known systemic teratogenic effects.
- EDTA is widely utilized as an ophthalmic drug, necessitating safety evaluations for topical application.
Purpose of the Study:
- To investigate the potential teratogenic and embryopathic effects of topically applied EDTA in ocular treatments.
- To assess the safety profile of different concentrations of EDTA (0.1% and 3%) used in ophthalmic preparations.
Main Methods:
- Topical application of 0.1% and 3% EDTA solutions to the eye in a preclinical model.
- Evaluation of progeny for teratogenic and embryopathic outcomes following maternal exposure.
Main Results:
- Neither 0.1% nor 3% EDTA solutions demonstrated teratogenic effects when applied topically.
- A significant embryopathic effect was observed with 3% EDTA applied six times daily, resulting in only 30% of normal progeny.
Conclusions:
- Topical ocular application of low-concentration EDTA (0.1%) appears safe regarding teratogenicity.
- High-concentration (3%) EDTA, when applied frequently to the eye, poses a risk of embryopathic effects and should be used with caution in ophthalmic treatments.